FOLFIRINOX vs gemcitabine nab-paclitaxel: A real-world efficacy and safety analysis - a single-centre experience

被引：0
|
作者：
Khan, A. M. [1 ]
Noor, S. [2 ]
Ahmed, R. [3 ]
Takreem, S. [2 ]
Shahnoor, S. S. [2 ]
Muddu, V. K. [2 ,4 ]
Bonda, A. [5 ]
Siripurapu, I. [5 ]
Krishnaiah, S. [6 ]
Rao, G. [7 ]
Reddy, N. [8 ]
机构：
[1] Asian Inst Gastroenterol, Dept Med Oncol, Hyderabad, India
[2] Anwarul Uloom Coll Pharm, Pharm Practice, Hyderabad, India
[3] Anwarul Uloom Coll Pharm, Pharm, Hyderabad, India
[4] AIG Hosp Hyderabad, Med Oncol, Hyderabad, India
[5] AIG Hosp, Dept Med Oncol, Hyderabad, India
[6] Asian Inst Gastroenterol, Biostat, Hyderabad, India
[7] Asian Inst Gastroenterol, Surg Gastroenterol, Hyderabad, India
[8] Asian Inst Gastroenterol, Med Gastroenterol, Hyderabad, India
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
376P
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience
    Ghorani, Ehsan
    Wong, Han Hsi
    Hewitt, Carole
    Calder, Joanna
    Corrie, Pippa
    Basu, Bristi
    ONCOLOGY, 2015, 89 (05) : 281 - 287
  • [42] Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data
    Boyne, Devon J.
    Brenner, Darren R.
    Gupta, Alind
    Mackay, Eric
    Arora, Paul
    Wasiak, Radek
    Cheung, Winson Y.
    Hernan, Miguel A.
    ANNALS OF EPIDEMIOLOGY, 2023, 78 : 28 - 34
  • [43] Adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for resected pancreatic ductal adenocarcinoma: A single center experience in China
    Zhu-Zeng Yin
    Zhi-Ming Zhao
    Wen-Bo Tang
    Nan Jiang
    Ke-Di Zhang
    Yu-Yao Song
    Yang Wang
    Cheng-Gang Li
    Yuan-Xing Gao
    Rong Liu
    World Journal of Clinical Cases, 2020, (13) : 2778 - 2786
  • [44] Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review (vol 11, pg 1, 2019)
    Chiorean, Elena Gabriela
    Cheung, Winson Y.
    Giordano, Guido
    Kim, George
    Al-Batran, Salah-Eddin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [45] Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting
    F. Franco
    J. C. Camara
    J. I. Martín-Valadés
    A. López-Alfonso
    D. Marrupe
    D. Gutiérrez-Abad
    B. Martínez-Amores
    A. León
    I. Juez
    M. Pérez
    A. Royuela
    A. Ruiz-Casado
    Clinical and Translational Oncology, 2021, 23 : 812 - 819
  • [46] Adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for resected pancreatic ductal adenocarcinoma: A single center experience in China
    Yin, Zhu-Zeng
    Zhao, Zhi-Ming
    Tang, Wen-Bo
    Jiang, Nan
    Zhang, Ke-Di
    Song, Yu-Yao
    Wang, Yang
    Li, Cheng-Gang
    Gao, Yuan-Xing
    Liu, Rong
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (13) : 2778 - 2786
  • [47] Efficacy and safety of neoadjuvant Folfirinox and Gemcitabine plus Nab-Paclitaxel for borderline resectable and locally advanced pancreatic cancer: a systematic review and meta-analysis
    Dong, L. -p.
    Liu, Y. -m.
    Lu, W. -j.
    Tang, K. -z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (17) : 6316 - 6327
  • [48] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Hakon Blomstrand
    Ursula Scheibling
    Charlotte Bratthäll
    Henrik Green
    Nils O. Elander
    BMC Cancer, 19
  • [49] Retrospective analysis of institutional outcomes with FOLFIRINOX versus nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Singh, Amisha
    Shroff, Rachna T.
    McBride, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [50] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Blomstrand, Hakon
    Scheibling, Ursula
    Bratthall, Charlotte
    Green, Henrik
    Elander, Nils O.
    BMC CANCER, 2019, 19 (1)
12345